Sharon Weinberg

Blackstone Alternative Alpha Fund is a non-diversified, closed-end management investment company. Its investment objective is to seek to earn long-term risk-adjusted returns. The company was founded on April 1, 2012 and is headquartered in New York, NY.

Pinpoint Therapeutics, Inc. provides cancer treatment. The firm specializes in developing novel treatments for cancer. The company was founded by Jeffrey Winkler and Ravi Amaravadi in 2018 and is headquartered in Philadelphia, PA.

1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA.

Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York.

Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ.

Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati.

Wfl Real Estate Services, LLC provides commercial property management and construction services. The private company is based in Norwalk.

Founded in 1993, Weston Capital Management LLC is a registered investment management firm located in Westport, Connecticut. The firm manages a hedge fund-of-fund as well as separate portfolios for private and institutional clients.

CPG Vintage Access Fund V LLC operates as a specialized investment vehicle. Its investment objective is to seek long-term attractive risk-adjusted returns. The firm makes investments in investment funds that are represented on the Morgan Stanley Platform. The company is headquartered in New York, NY.

Part of Macquarie Group Ltd., Central Park Group, LLC is a company that offers private equity, hedge fund, real estate, and fund-of-funds investments tailored for institutions and qualified private client investors. The company is based in New York, NY. The CEOs are Gregory P. Brousseau and Mitchell A. Tanzman. The company was founded in 2006. Central Park Group was acquired by Macquarie Asset Management Pty Ltd. on March 14, 2022.

CPG Vintage Access Fund IV LLC is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term attractive risk-adjusted returns. The fund to achieve its investment objective principally by making primary investments in a portfolio of institutional private equity, venture and private debt investment funds managed or sponsored by various asset management firms. CPG Vintage Access Fund IV is headquartered in New York, NY.

Stroock & Stroock & Lavan LLP provides legal services. It is a law firm, which provides transactional and litigation guidance to multinational corporations, investment banks & venture capital firms in the U.S. and abroad. Its practice areas include corporate finance and legal services to financial institutions, energy, financial restructuring, insurance, intellectual property, litigation, and real estate. The company was founded in 1876 and is headquartered in New York, NY.

Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY.

Central Park Advisers LLC (Central Park Group) is a private equity subsidiary of Central Park Group LLC founded in 2006 by Gregory P. Brousseau and Mitchell Tanzman. The firm is headquartered in New York.

TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer.